World important news by Maegan

RSS

Consumption trends eyed as Danone reports Q3 sales


* Q3 underlying sales growth seen up 5.6 pct - Rtrs pollBy Dominique VidalonPARIS, Oct 18 (Reuters) - Consumption trends for the rest of the year and in 2012 amid global recession fears will be in focus along with the outlook for commodity prices when French food group Danone reports third quarter sales on Tuesday.The world’s largest yoghurt maker is expected to post higher sales but slower growth in the third quarter as challenges in the Russian and U.S. dairy markets and a return to more normal growth rates at its water business take their toll, and investors will be keen to hear whether the weakness is temporary.”Investors are also likely to watch for any initial guidance on 2012 input cost inflation, which should be more benign than 2011” Societe Generale analysts said in a note.Analysts polled by Reuters on average expect Danone to post third-quarter sales of 4.8 billion euros, a reported rise of 10.6 percent. Closely-watched underlying sales growth is forecast at 5.6 percent.This would mark a slowdown from 8.7 percent in the first half. Danone Chief Executive Franck Riboud said last month he expected underlying growth of 5-6 percent in the quarter.Danone, whose brands include Actimel and Activia, at the time kept its targets for full-year underlying sales growth of 6-8 percent and for an improvement in operating margin of 20 basis points.Danone has forecast a rise of 6-9 percent in commodity costs this year and it raised its prices during the first half to combat this expected rise.Attention will also focus on the newly acquired Russian Unimilk business, which has suffered from higher milk costs and a repositioning of the business towards higher value-added milk products, which comes at the expense of sales volumes.Russia accounts for 11 percent of Danone’s sales, as does France, and they are the two top contributors to group sales.Meanwhile, the U.S. market, where Danone generates 8 percent of sales, has been seeing strong growth in the Greek yoghurt segment, which has cannibalised other areas where Danone has a stronger presence, analysts said. To address that situation, Danone relaunched a Greek yoghurt in July in the United States.Danone’s water business was boosted in the second quarter by strong demand from Japan after the Fukushima nuclear disaster and by warm weather in Europe. Third-quarter water sales are expected to reflect poorer weather in Western Europe.Danone’s acquisition strategy will also be in focus after it said it was on the lookout for expansion in fast-growing markets.

Eastern European teams struggling in Champions League


If the opening two rounds in the Champions League group stage are anything to go by, eastern European teams in the competition will find it difficult to advance to the knockout stage. As things stand at the moment, most of them could also be denied the consolation prize of carrying on in the Europa League after the winter break. Teams from this part of Europe registered just one win, one draw and five defeats on Tuesday and Wednesday and most have a mountain to climb if they are to reach the last 16. Five of them — CSKA Moscow, Otelul Galati, Dinamo Zagreb, Shakhtar Donetsk and Viktoria Plzen are bottom in their respective groups. BATE Borisov, who were handed a 5-0 drubbing by holders Barcelona in Belarus, also have a very slim chance of progressing, while only Zenit St. Petersburg look likely to reach the last 16 after an impressive 3-1 home win against 2004 winners Porto. Can eastern European teams catch up with their western rivals and mount a sustained challenge? Even the wealthy and strong among them struggle to keep up. Shakhtar reached the quarter-finals last season after winning the 2009 UEFA Cup but although they enjoyed a relatively kind draw this term, they made a poor start after taking just one point from their opening two games. On the other hand, some less familiar names from the western half of the continent are fighting with a cluster of usual suspects already looking assured of advancing into the knockout stage of the competition. Cypriots APOEL Nicosia (‘western’ historically if not geographically), Swiss upstarts Basel and Italian hopefuls Napoli, who last played in the Europe’s premier club competition when they had a certain Diego Maradona in their ranks, have all made bright starts and could reach the latter stages of the competition at the expense more heralded opposition. Or, will the business end turn out to be a predictable clash of the titans? How long can the underdogs and the dark horses keep up with the favourites? PHOTO: AC Milan’s Clarence Seedorf (L) challenges Frantisek Rajtoral of Viktoria Plzen during their Champions League Group H soccer match at the San Siro September 28, 2011.

UPDATE 1-Ista eye drug trials show mixed results


Ista was testing its drug Prolensa in two late-stage trials as a treatment of inflammation and pain in patients who have undergone cataract extraction.The company plans to file the marketing application for Prolensa in the first quarter of 2012, with a commercial launch planned for late 2012 or early 2013.The company was also testing Remura that had earlier failed to show a statistically significant improvement over the placebo in the first late-stage trial, known as West, in July.Dry eye disease occurs due to imbalance of tears that can result in pain, itching, redness, blurry vision, light sensitivity and feeling of sand in the eye.In the second-late stage trial, known as East, Remura failed to show statistically significant improvement in symptoms of patients suffering with dry eye, compared to patients taking placebo.”We will complete a full analysis of the data, but focus our efforts on the potential use of the vehicle as an over-the-counter artificial tear product,” Ista said in a statement.Shares of Ista closed at $3.79 on Wednesday on Nasdaq.